Clinical Trial Update: Insulin Glargine Versus Twice-Daily NPH [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin glargine to twice-daily NPH in type 2 diabetes was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NPH (insulin NPH)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2010-10-07